fluconazole has been researched along with Birth Weight in 11 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
" The authors conducted the first prospective, randomised controlled trial of nystatin compared with fluconazole for the prevention of fungal colonisation and invasive fungal infection in very low birth weight (VLBW) neonates." | 9.15 | Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. ( Akar, M; Aydemir, C; Dilmen, U; Dizdar, EA; Erdeve, O; Oguz, SS; Sarikabadayi, YU; Saygan, S, 2011) |
"This observational pre-post cohort study was performed in preterm infants with a birth weight of < 1,000 g who were given prophylactic fluconazole starting on the first postnatal day at a dose of 3 mg/kg twice a week." | 7.80 | Efficacy of prophylactic fluconazole therapy in decreasing the incidence of Candida infections in extremely low birth weight preterm infants. ( Buyukkale, G; Cetinkaya, M; Ercan, TE; Kavuncuoglu, S; Mete, F; Saglam, OK, 2014) |
"Fluconazole is an effective agent for prophylaxis of invasive candidiasis in premature infants." | 6.82 | Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams. ( Benjamin, DK; Capparelli, EV; Cummings, JJ; Dhanireddy, R; Gao, J; Hudak, ML; Kantak, A; Laughon, M; Momper, JD; Mundakel, GT; Natarajan, G; Nedrelow, JH; Smith, PB; Wade, KC, 2016) |
" The authors conducted the first prospective, randomised controlled trial of nystatin compared with fluconazole for the prevention of fungal colonisation and invasive fungal infection in very low birth weight (VLBW) neonates." | 5.15 | Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants. ( Akar, M; Aydemir, C; Dilmen, U; Dizdar, EA; Erdeve, O; Oguz, SS; Sarikabadayi, YU; Saygan, S, 2011) |
"Fluconazole seems to be an effective therapy for systemic and other forms of candidiasis in infants including very low birth weight infants (VLBWI; <1500 g)." | 5.09 | Treatment of candidal infections with fluconazole in neonates and infants. ( Penk, A; Pittrow, L; Schwarze, R, 2000) |
"This observational pre-post cohort study was performed in preterm infants with a birth weight of < 1,000 g who were given prophylactic fluconazole starting on the first postnatal day at a dose of 3 mg/kg twice a week." | 3.80 | Efficacy of prophylactic fluconazole therapy in decreasing the incidence of Candida infections in extremely low birth weight preterm infants. ( Buyukkale, G; Cetinkaya, M; Ercan, TE; Kavuncuoglu, S; Mete, F; Saglam, OK, 2014) |
"Fluconazole resistance was present in 16 of 32 cases of C." | 2.49 | Background changing patterns of neonatal fungal sepsis in a developing country. ( Ballot, DE; Bosman, N; Cooper, PA; Nana, T; Ramdin, T, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Cook, A | 1 |
Ferreras-Antolin, L | 1 |
Adhisivam, B | 1 |
Ballot, D | 1 |
Berkley, JA | 1 |
Bernaschi, P | 1 |
Carvalheiro, CG | 1 |
Chaikittisuk, N | 1 |
Chen, Y | 1 |
Chibabhai, V | 1 |
Chitkara, S | 1 |
Chiurchiu, S | 1 |
Chorafa, E | 1 |
Dien, TM | 1 |
Dramowski, A | 1 |
de Matos, SF | 1 |
Feng, J | 1 |
Jarovsky, D | 1 |
Kaur, R | 1 |
Khamjakkaew, W | 1 |
Laoyookhong, P | 1 |
Machanja, E | 1 |
Mussi-Pinhata, MM | 1 |
Namiiro, F | 1 |
Natraj, G | 1 |
Naziat, H | 1 |
Ngoc, HTB | 1 |
Ondongo-Ezhet, C | 1 |
Preedisripipat, K | 1 |
Rahman, H | 1 |
Riddell, A | 1 |
Roilides, E | 1 |
Russell, N | 1 |
Sastry, AS | 1 |
Tasimwa, HB | 1 |
Tongzhen, J | 1 |
Wadula, J | 1 |
Wang, Y | 2 |
Whitelaw, A | 1 |
Wu, D | 1 |
Yadav, V | 1 |
Yang, G | 1 |
Stohr, W | 1 |
Bielicki, JA | 1 |
Ellis, S | 1 |
Warris, A | 1 |
Heath, PT | 1 |
Sharland, M | 1 |
Yadav, A | 1 |
Jain, P | 1 |
Jain, K | 1 |
Singh, A | 2 |
Xu, J | 1 |
Chowdhary, A | 1 |
Ballot, DE | 1 |
Bosman, N | 1 |
Nana, T | 1 |
Ramdin, T | 1 |
Cooper, PA | 1 |
Cetinkaya, M | 1 |
Ercan, TE | 1 |
Saglam, OK | 1 |
Buyukkale, G | 1 |
Kavuncuoglu, S | 1 |
Mete, F | 1 |
Fernandez Rodriguez, B | 1 |
Peña Gonzalez, L | 1 |
Calvo, MC | 1 |
Chaves Sanchez, F | 1 |
Pallas Alonso, CR | 1 |
de Alba Romero, C | 1 |
Momper, JD | 1 |
Capparelli, EV | 1 |
Wade, KC | 1 |
Kantak, A | 1 |
Dhanireddy, R | 1 |
Cummings, JJ | 1 |
Nedrelow, JH | 1 |
Hudak, ML | 1 |
Mundakel, GT | 1 |
Natarajan, G | 1 |
Gao, J | 1 |
Laughon, M | 1 |
Smith, PB | 1 |
Benjamin, DK | 1 |
Aydemir, C | 1 |
Oguz, SS | 1 |
Dizdar, EA | 1 |
Akar, M | 1 |
Sarikabadayi, YU | 1 |
Saygan, S | 1 |
Erdeve, O | 1 |
Dilmen, U | 1 |
Fridkin, SK | 1 |
Kaufman, D | 1 |
Edwards, JR | 1 |
Shetty, S | 1 |
Horan, T | 1 |
Manzoni, P | 1 |
Monstert, M | 1 |
Agriesti, G | 1 |
Priolo, C | 1 |
Galletto, P | 1 |
Farina, D | 1 |
Rabalais, GP | 1 |
Samiec, TD | 1 |
Bryant, KK | 1 |
Lewis, JJ | 1 |
Schwarze, R | 1 |
Penk, A | 1 |
Pittrow, L | 1 |
2 reviews available for fluconazole and Birth Weight
Article | Year |
---|---|
Background changing patterns of neonatal fungal sepsis in a developing country.
Topics: Antifungal Agents; Birth Weight; Candida; Candidemia; Candidiasis; Drug Resistance, Fungal; Female; | 2013 |
Neonatal fungal infections: the state of the art.
Topics: Antifungal Agents; Birth Weight; Candidiasis; Clinical Trials as Topic; Fluconazole; Fungemia; Gesta | 2007 |
4 trials available for fluconazole and Birth Weight
Article | Year |
---|---|
Oral care in a neonatal intensive care unit.
Topics: Amphotericin B; Anti-Bacterial Agents; Birth Weight; Chemoprevention; Cross Infection; Female; Fluco | 2017 |
Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.
Topics: Antifungal Agents; Birth Weight; Female; Fluconazole; Humans; Infant; Infant, Newborn; Infant, Prema | 2016 |
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants.
Topics: Antifungal Agents; Birth Weight; Disease Progression; Drug Resistance, Fungal; Epidemiologic Methods | 2011 |
Treatment of candidal infections with fluconazole in neonates and infants.
Topics: Antifungal Agents; Birth Weight; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Infant; | 2000 |
5 other studies available for fluconazole and Birth Weight
Article | Year |
---|---|
Neonatal invasive candidiasis in low- and middle-income countries: Data from the NeoOBS study.
Topics: Antifungal Agents; Birth Weight; Candida; Candida albicans; Candida parapsilosis; Candidiasis, Invas | 2023 |
Genomic Analyses of a Fungemia Outbreak Caused by Lodderomyces elongisporus in a Neonatal Intensive Care Unit in Delhi, India.
Topics: Adult; Antifungal Agents; Birth Weight; Disease Outbreaks; Fluconazole; Fungemia; Genomics; Humans; | 2023 |
Efficacy of prophylactic fluconazole therapy in decreasing the incidence of Candida infections in extremely low birth weight preterm infants.
Topics: Antifungal Agents; Birth Weight; Candidiasis, Invasive; Female; Fluconazole; Gestational Age; Humans | 2014 |
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
Topics: Antifungal Agents; Birth Weight; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Flu | 2006 |
Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit.
Topics: Amphotericin B; Antifungal Agents; Birth Weight; Candidiasis; Congenital Abnormalities; Female; Fluc | 1996 |